Answers are grounded in this paper and cite their sources.
Oral and intravenous acyclovir formulations provide effective virostasis against many herpes viruses infections, especially severe herpes simplex or varicella-zoster infections in ambulatory and immunocompromised patients. The therapeutic virostatic efficacy of topical acyclovir formulations requires further development, however, especially for orolabial herpetic infections.
No takes yet. Share an insight, caveat, or question.
C.L.B. Lavelle (1993) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: